Filtros de búsqueda

Lista de obras de

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

artículo científico publicado en 2017

A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association

artículo científico publicado en 2012

A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life

artículo científico publicado en 2008

A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.

artículo científico publicado en 2011

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

artículo científico publicado en 2010

A randomized trial of iloprost in patients with intermittent claudication

artículo científico publicado en 2008

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication

artículo científico publicado en 2013

A validated biomarker panel to identify peripheral artery disease

artículo científico publicado en 2012

Acute Limb Ischemia in Peripheral Artery Disease

artículo científico publicado en 2019

Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration

scientific article published on 01 June 2008

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes

artículo científico publicado en 2007

Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training

artículo científico publicado en 2012

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

artículo científico

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

artículo científico publicado en 2015

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering

artículo científico publicado en 2015

An aspirin a day: are we barking up the wrong willow tree?

artículo científico publicado en 2010

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering

artículo científico publicado en 2015

Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients

artículo científico publicado en 2011

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

artículo científico publicado en 2008

Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (

artículo científico publicado en 2009

Antithrombotic Therapy for Peripheral Artery Disease in 2018

artículo científico publicado en 2018

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication

artículo científico publicado en 2011

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial

artículo científico publicado en 2007

Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease

artículo científico publicado en 2017

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

artículo científico publicado en 2009

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials

artículo científico publicado en 2011

Aspirin in primary prevention: can we individualize care?

artículo científico publicado en 2012

Assessing the clinical benefits of lipid-disorder drugs

artículo científico publicado en 2014

Assessment of functional status and quality of life in claudication

artículo científico publicado en 2011

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults

artículo científico publicado en 2014

Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial

artículo científico publicado en 2020

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial

artículo científico publicado en 2020

Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial

scientific article published on 31 August 2020

Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease

artículo científico publicado en 2020

Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease

artículo científico publicado en 2013

Association of perceived stress with health status outcomes in patients with peripheral artery disease

scientific article published on 24 November 2020

Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary

scientific article published on 01 December 2008

Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases

artículo científico publicado en 2008

Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology

artículo científico publicado en 2004

Automated Detection of Exercise Sessions in Patients With Peripheral Artery Disease: EVIDENCE FOR AN EXERCISE DOSE RESPONSE TO TRAINING

artículo científico publicado en 2020

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation

article

Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention

artículo científico publicado en 2005

CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial

artículo científico publicado en 2020

Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial

artículo científico publicado en 2018

Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium

artículo científico

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial

artículo científico publicado en 2018

Cardiovascular drug development: is it dead or just hibernating?

artículo científico

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

artículo científico publicado en 2014

Cardiovascular risk assessment in the development of new drugs for obesity

artículo científico publicado en 2012

Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial

artículo científico publicado en 2020

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

artículo científico publicado en 2003

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial

scientific article published on 24 July 2019

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations

artículo científico publicado en 2016

Clinical and demographic predictors of exercise capacity in end-stage renal disease

artículo científico publicado en 2002

Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia

scientific article published on July 2009

Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database

artículo científico publicado en 2014

Community walking programs for treatment of peripheral artery disease

artículo científico publicado en 2013

Community-based walking exercise for peripheral artery disease: An exploratory pilot study

artículo científico publicado en 2015

Current medical therapies for patients with peripheral arterial disease: a critical review

artículo científico publicado en 2002

Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial

artículo científico publicado en 2016

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

artículo científico publicado en 2004

Effect of Propionyl-L-carnitine on a Background of Monitored Exercise in Patients With Claudication Secondary to Peripheral Artery Disease ⬇️

artículo científico publicado el 1 de marzo de 2011

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials

artículo científico publicado en 2002

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

artículo científico publicado en 2011

Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.

artículo científico

Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease

artículo científico publicado en 2010

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

artículo científico publicado en 2014

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

artículo científico publicado en 2019

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

artículo científico publicado en 2014

Evaluating effects of method of administration on Walking Impairment Questionnaire

artículo científico publicado en 2003

Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?

scientific article published on 01 May 2016

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

artículo científico publicado en 2015

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

artículo científico

Exercise training for claudication

artículo científico publicado en 2002

Fibrates in the treatment of dyslipidemias--time for a reassessment

artículo científico publicado en 2011

Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death

artículo científico publicado en 2016

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

artículo científico publicado en 2020

Functional outcome in a contemporary series of major lower extremity amputations

artículo científico publicado en 2003

Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease

artículo científico publicado en 2018

Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different

scientific article published on 01 July 2019

Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial

scientific article published on 04 October 2019

Impaired muscle oxygen use at onset of exercise in peripheral arterial disease.

artículo científico publicado en 2004

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model ⬇️

artículo científico publicado el 10 de noviembre de 2010

Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial

artículo científico publicado en 2020

Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial

artículo científico publicado en 2019

Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease

article

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

artículo científico publicado en 2003

Is revascularization and limb salvage always the best treatment for critical limb ischemia?

artículo científico publicado en 2003

L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2012

Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes ⬇️

artículo científico publicado el 1 de abril de 2003

Lack of relationship between gait parameters and physical function in peripheral arterial disease

artículo científico publicado en 2006

Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization

artículo científico publicado en 2020

Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).

artículo científico publicado en 2007

Lost in translation: Why 'lost to follow-up' matters

artículo científico publicado en 2019

Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization

scientific article published on 01 August 2018

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

scientific article published on 18 November 2019

Managing abnormal blood lipids: a collaborative approach

artículo científico publicado en 2005

Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication

artículo científico publicado en 2006

Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association

artículo científico publicado en 2012

Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study

artículo científico publicado en 2008

Medical therapy in peripheral artery disease

artículo científico

No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials

scientific article published on 01 April 2020

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

artículo científico publicado en 2019

Optimal assessment of baseline treadmill walking performance in claudication clinical trials

artículo científico publicado en 2007

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial

artículo científico publicado en 2017

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes

artículo científico publicado en 2017

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

artículo científico publicado en 2006

Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design.

artículo científico publicado en 2008

Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.

artículo científico publicado en 2016

Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis

artículo científico publicado en 2002

Peripheral arterial disease rehabilitation: a review

artículo científico publicado en 2003

Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

artículo científico publicado en 2020

Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries

artículo científico publicado en 2016

Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting

artículo científico publicado en 2012

Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia

artículo científico publicado en 2013

Prognostic value of an increase in post-exercise ankle-brachial index

artículo científico publicado en 2016

Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back

artículo científico publicado en 2020

Progression of asymptomatic peripheral artery disease over 1 year

artículo científico publicado en 2012

Pulmonary VO2 dynamics during treadmill and arm exercise in peripheral arterial disease

scientific article published on 16 April 2004

Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials

artículo científico publicado en 2005

Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy

artículo científico publicado en 2004

Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells

artículo científico publicado en 2014

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

artículo científico publicado en 2018

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

artículo científico

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

article

Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs

artículo científico publicado en 2015

Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease

artículo científico publicado en 2011

Reply: Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial

artículo científico publicado en 2016

Response by Brass and Hiatt to Letter Regarding Article, "Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease"

artículo científico publicado en 2018

Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) In

artículo científico publicado en 2017

Response by Jones et al to Letter Regarding Article, "Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease".

artículo científico publicado en 2017

Response to McDermott

Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies

artículo científico publicado en 2006

Risk assessment in drug development for symptomatic indications: a framework for the prospective exclusion of unacceptable cardiovascular risk

artículo científico publicado en 2006

Risk assessment in the patient with established peripheral arterial disease

artículo científico publicado en 2007

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

artículo científico publicado en 2020

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

artículo científico publicado en 2018

Rivaroxaban in Peripheral Artery Disease after Revascularization

scientific article published on 28 March 2020

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

artículo científico publicado en 2020

Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease

artículo científico publicado en 2020

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

artículo científico publicado en 2014

Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease

artículo científico publicado en 2007

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function

artículo científico publicado en 2013

Stroke in Patients With Peripheral Artery Disease

scientific article published on 16 May 2019

TASC II section F on revascularization in PAD.

artículo científico publicado en 2007

Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD

scientific article published on 29 January 2020

The Development of Therapeutics for Peripheral Artery Disease: A Unique Cardiovascular Risk Population

artículo científico publicado en 2016

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE

article

The Pathobiology of Acute Limb Ischemic Events and Stent Failure in Peripheral Artery Disease: A Step in the Right Direction

artículo científico publicado en 2020

The Society for Vascular Medicine: the first quarter century

artículo científico publicado en 2015

The Treatment Gap in Peripheral Artery Disease

artículo científico publicado en 2017

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience

artículo científico publicado en 2013

The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease

artículo científico publicado en 2004

The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.

artículo científico publicado en 2008

The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease

artículo científico publicado en 2006

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease

artículo científico

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

artículo científico publicado en 2016

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution

scientific article published on 09 April 2018

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

artículo científico publicado en 2016

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial

scientific article published on 11 July 2018

Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial

artículo científico publicado en 2003

Treatment of peripheral arterial disease

artículo científico publicado en 2002

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

artículo científico

Use of ankle brachial index screening for selecting patients for antiplatelet drug therapy

artículo científico publicado en 2005

Utility and barriers to performance of the ankle brachial index in primary care practice

article

What cost weight loss?

artículo científico publicado en 2012

Why TASC II?

artículo científico publicado en 2007

Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda